共查询到20条相似文献,搜索用时 8 毫秒
1.
2.
3.
《Health policy (Amsterdam, Netherlands)》2018,122(6):621-629
The increasing demand for healthcare and the resulting pressure on available budgets render priority setting inevitable. If societies aim to improve health and distribute health(care) fairly, equity-efficiency trade-offs are necessary. In the Netherlands, proportional shortfall (PS) was introduced to quantify necessity of care, allowing a direct equity-efficiency trade-off. This study describes the history and application of PS in the Netherlands and examines the theoretical and empirical support for PS as well as its current role in healthcare decision making. We reviewed the international literature on PS from 2001 onwards, along with publicly accessible meeting reports from the Dutch appraisal committee, Adviescommissie Pakket (ACP), from 2013 to 2016. Our results indicate that there is support for the decision model in which necessity is quantified and incremental cost-effectiveness ratios are evaluated against associated monetary reference values. The model enables a uniform framework for priority setting across all healthcare sectors. Although consensus about the application of PS has not yet been reached and alternative ways to quantify necessity were found in ACP reports, PS has increasingly been applied in decision making since 2015. However, empirical support for PS is limited and it may insufficiently reflect societal preferences regarding age and reducing lifetime-health inequalities. Hence, further investigation into refining PS—or exploration of another approach—appears warranted for operationalising the equity-efficiency trade-off. 相似文献
4.
5.
6.
One of the toughest and most important issues facing America today is healthcare reform. To examine this issue more closely, four industry observers were invited to share their thoughts with Healthcare Executive. 相似文献
7.
8.
9.
10.
Richards LV 《Medical education》2003,37(12):1062-1063
11.
12.
13.
14.
Patient advocacy is based on the premise that people have the right to make their own choices about their health care. Personal advocacy is centred on the experiential expertise of the individual affected by the condition, whereas group advocacy is grounded on patient-centred strategies and actions. The first patient advocacy groups for arthritis were set up over 20 years ago in the USA and have subsequently spread to many other countries. This paper discusses the growth and impact of personal advocacy as well as recent developments in group advocacy in the Asia-Pacific region, Europe, and North America, in terms of arthritis awareness, research, corporate partnerships, and the Bone and Joint Decade global initiative. 相似文献
15.
16.
17.
18.
BCG and HIV reconsidered: moving the research agenda forward 总被引:2,自引:0,他引:2
Hesseling AC Cotton MF Marais BJ Gie RP Schaaf HS Beyers N Fine PE Abrams EJ Godfrey-Faussett P Kuhn L 《Vaccine》2007,25(36):6565-6568
19.
20.